Primary Prevention of Arterial Thromboembolism in Nonrheumatic Atrial Fibrillation: The PATAF Trial Study Design
- 31 August 1999
- journal article
- clinical trial
- Published by Elsevier in Controlled Clinical Trials
- Vol. 20 (4) , 386-393
- https://doi.org/10.1016/s0197-2456(99)00010-0
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Effect of Fixed Minidose Warfarin, Conventional Dose Warfarin and Aspirin on INR and Prothrombin Fragment 1 + 2 in Patients with Atrial FibrillationThrombosis and Haemostasis, 1997
- Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomised clinical trialThe Lancet, 1996
- Should all patients with atrial fibrillation receive warfarin? Evidence from randomized clinical trialsEuropean Heart Journal, 1996
- Risk Factors for Stroke and Efficacy of Antithrombotic Therapy in Atrial FibrillationArchives of internal medicine (1960), 1994
- Warfarin in the Prevention of Stroke Associated with Nonrheumatic Atrial FibrillationNew England Journal of Medicine, 1992
- Stroke Prevention in Atrial Fibrillation Study. Final results.Circulation, 1991
- Nonrheumatic atrial fibrillation. Risk of stroke and role of antithrombotic therapy.Circulation, 1991
- PLACEBO-CONTROLLED, RANDOMISED TRIAL OF WARFARIN AND ASPIRIN FOR PREVENTION OF THROMBOEMBOLIC COMPLICATIONS IN CHRONIC ATRIAL FIBRILLATIONThe Lancet, 1989
- Epidemiologic Features of Chronic Atrial FibrillationNew England Journal of Medicine, 1982
- Epidemiologic assessment of chronic atrial fibrillation and risk of strokeNeurology, 1978